Duvelisib Plus Docetaxel In Recurrent/Metastatic HNSCC

NCT05057247 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Carcinoma of the Head and Neck (SCCHN)
Recurrent Squamous Cell Carcinoma of the Head and Neck
Metastatic Head and Neck Cancer
Advanced Head and Neck Cancer
Advanced Head and Neck Squamous Cell Carcinoma

Interventions

DRUG: Duvelisib
DRUG: Docetaxel

Sponsor

Glenn J. Hanna

Collaborators

[object Object]